Suggestions
Sam Gray
Healthcare Investor
Sam Gray is a highly experienced healthcare investor with over 20 years of experience in the global healthcare sector. He has a strong focus on investing in rapidly growing private SME healthcare companies through buy-out and growth investments. Sam has an extensive background as an Investor Director of healthcare services, digital health, and medical products companies in the UK, US, and continental Europe.
Sam graduated with an MBA from Harvard Business School and a BA (hons)/MSci from the University of Cambridge. He is currently the Managing Partner at Apposite Capital, and he is a former Investor Director at several companies such as Mirada Medical, Swanton Care & Community, MC Care, and more.
Over the years, Sam has demonstrated his hands-on approach by working with management on business building, strategy, business development, M&A, debt and equity financings, culminating in multiple successful exits. He has a track record of successfully raising and deploying top quartile private equity funds and building out investment teams.
Sam has served in different capacities, including being a Former Member of Biomedical Catalyst Major Awards Committee at Innovate UK, Investor and Board Observer at By The Bridge, Summer Associate at Warburg Pincus, Business Development Executive at UCB Biopharma, and Mergers & Acquisitions Banker at Deutsche Bank.
Highlights
Exciting times for Mirada Medical and TeleDaaS with launch of the world's first dosimetry-as-a-service for radiopharmaceuticals.
TeleDAAS gives uncomplicated access to Mirada’s advanced dosimetry technology which has been used in multiple clinical trials to dramatically improve clinical outcomes.
In DOSISPHERE-1 which compared Mirada"s personalized dosimetry with standard dosimetry the benefits of personalized dosimetry were so stark that the trial was cut short because it was deemed unethical to assign patients to the standard dosimetry arm of the trial.
https://lnkd.in/exuVC8nd
#dosematters #radiopharmaceuticals #healthcareimpact
Great for Apposite Capital to be listed amongst the Top 10 most active private equity investors in European Healthcare and 1st for funds under £1bn.
Apposite’s current portfolio includes 13 European healthcare businesses located in 6 European countries UK, France, Italy, Spain, Denmark and Switzerland https://lnkd.in/egp2J2w4 #privateequity #healthcare #growthequity
